Maintaining the highest standards means we produce world-class solutions aimed at improving the quality of life for people with cancer.
“When my father, Dr. Gabriele Braglia, founded Helsinn in 1976, he had a simple pharmaceutical licensing business in mind. Now, over 40 years later, we’ve grown to around 680 committed employees, and together with our long-standing commercial and marketing partners, that are helping us create a large portfolio of cancer care and rare diseases therapies. As we move forward, we will never forget our fundamental objective: to build better todays for every person affected by cancer.”
Riccardo Braglia, Helsinn Group Vice Chairman and CEO
Our Mission, Vision, and Values
We are committed to making everything we do count towards the best therapies and supportive care for cancer patients—from the products we license to the rigorous standards we apply as a pharmaceutical manufacturer. At Helsinn we are committed to extending the reach of our quality care and use our expertise to fulfil more unmet needs and build better todays for more patients worldwide.
To bring better todays to even more people through a portfolio of quality innovative cancer and rare disease therapies.
To shape the Helsinn Group into one of the world’s leading cancer-care companies with a focus on improving patients’ quality of life.
We are a family-run company, and have retained our founding values of quality, integrity and respect, which guide everything we do.
Being honest, ethical and trustworthy is helping us become the cancer care partner of choice.
Treating our partners as we would like to be treated leads to strong, enduring relationships